Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN and MHC-I antigen cross processing by TLR9

被引：0
|
作者：
Simmons, Daimon [1 ]
Canaday, David [1 ]
Liu, Yi [1 ]
Boom, W. Henry [1 ]
Harding, Clifford [1 ]
机构：
[1] Case Western Reserve Univ, Pathol & Infect Dis, Cleveland, OH 44106 USA
来源：
JOURNAL OF IMMUNOLOGY | 2010年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
37.15
引用
收藏
页数：1
相关论文
共 31 条
  • [1] Mycobacterium tuberculosis and TLR2 Agonists Inhibit Induction of Type I IFN and Class I MHC Antigen Cross Processing by TLR9
    Simmons, Daimon P.
    Canaday, David H.
    Liu, Yi
    Li, Qing
    Huang, Alex
    Boom, W. Henry
    Harding, Clifford V.
    JOURNAL OF IMMUNOLOGY, 2010, 185 (04): : 2405 - 2415
  • [2] Mycobacterium tuberculosis and TLR2 agonists inhibit induction of type I IFN by TLR7/9
    Liu, Yi
    Simmons, Daimon
    Li, Xiaoxia
    Abbott, Derek
    Boom, W.
    Harding, Clifford
    JOURNAL OF IMMUNOLOGY, 2011, 186
  • [3] TRAM Is Required for TLR2 Endosomal Signaling to Type I IFN Induction
    Stack, Julianne
    Doyle, Sarah L.
    Connolly, Dympna J.
    Reinert, Line S.
    O'Keeffe, Kate M.
    McLoughlin, Rachel M.
    Paludan, Soren R.
    Bowie, Andrew G.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (12): : 6090 - 6102
  • [4] TLR2 Signaling Depletes IRAK1 and Inhibits Induction of Type I IFN by TLR7/9
    Liu, Yi C.
    Simmons, Daimon P.
    Li, Xiaoxia
    Abbott, Derek W.
    Boom, W. Henry
    Harding, Clifford V.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (03): : 1019 - 1026
  • [5] TLR9 and TLR7 agonists mediate distinct type I IFN responses in humans and nonhuman primates in vitro and in vivo
    Puig, Montserrat
    Tosh, Kevin W.
    Schramm, Lynnsie M.
    Grajkowska, Lucja T.
    Kirschman, Kevin D.
    Tami, Cecilia
    Beren, Joel
    Rabin, Ronald L.
    Verthelyi, Daniela
    JOURNAL OF LEUKOCYTE BIOLOGY, 2012, 91 (01) : 147 - 158
  • [6] TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis
    Bafica, A
    Scanga, CA
    Feng, CG
    Leifer, C
    Cheever, A
    Sher, A
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 202 (12): : 1715 - 1724
  • [7] Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours
    Babiker, H.
    Borazanci, E.
    Subbiah, V.
    Algazi, A. P.
    Schachter, J.
    Lotem, M.
    Hendler, D.
    Rahimian, S.
    Minderman, H.
    Haymaker, C.
    Bernatchez, C.
    Murthy, R.
    Hultsch, R.
    Caplan, N.
    Woodhead, G. J.
    Hennemeyer, C. T.
    Chunduru, S.
    Anderson, P.
    Diab, A.
    Puzanov, I.
    ANNALS OF ONCOLOGY, 2020, 31 : S711 - S712
  • [8] Impact of in vitro Costimulation with TLR2, TLR4 and TLR9 Agonists and HIV-1 on Antigen-Presenting Cell Activation
    Marcela Giraldo, Diana
    Carlos Hernandez, Juan
    Urcuqui Inchima, Silvio
    INTERVIROLOGY, 2015, 58 (02) : 122 - 129
  • [9] Staphylococcus aureus Induces Type I IFN Signaling in Dendritic Cells Via TLR9
    Parker, Dane
    Prince, Alice
    JOURNAL OF IMMUNOLOGY, 2012, 189 (08): : 4040 - 4046
  • [10] TLR9 and TLR7 mediate distinct type I IFN responses in humans and non-human primates
    Puig, Montserrat
    Tosh, Kevin W.
    Schramm, Lynnsie M.
    Grajkowska, Lucja T.
    Kirschman, Kevin D.
    Tami, Cecilia
    Beren, Joel
    Rabin, Ronald L.
    Verthelyi, Daniela
    CYTOKINE, 2011, 56 (01) : 9 - 9
1234